Groowe Groowe / Newsroom / LLY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

LLY News

Eli Lilly & Co.

Morgan & Morgan Announces Record-Breaking Year Of Awards

globenewswire.com
GOOGL LLY NSC META XOM

MMA Announces SMARTIES™ X Global 2025 Winners: Honoring Marketing That Drives Global Impact USA - English India - English APAC - English

prnewswire.com
ADBE AMZN T BAC BCG CPB DAL DIS LLY XOM F GM GOOG HRL HSY HLT HD IPG JPM K KR LINK MAR MA MCD MRK META MSFT MOS MS NFLX PINS PPG PRG ROKU CRM SMG SNA SFTBY TGT TTD TMUS TU UBER UL V WMT

Is SkinnyRx the Best GLP-1 Vendor for 2026? Platform Offers Compounded Semaglutide in Three Forms Starting at $199/Month as New Year Weight Loss Season Approaches

globenewswire.com
WGO AMGN LLY

Sacred Stories Project to Amplify Christian Vocational Narratives

globenewswire.com
LLY

Rise of Direct-to-Patient GLP-1 Sales Shakes Up Care Models, HCPs Split on Pharma’s Expanding Role

businesswire.com
LLY NVO

Peptide Therapeutics Market Size to Surpass USD 87.21 Billion by 2035 Driven by Rising Cancer, Diabetes, and Demand for Targeted Therapies

globenewswire.com
LLY AMGN PFE

Lilly's orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial

prnewswire.com
LLY

Confo Therapeutics Nominates SSTR5 Agonist Antibody CFTX-2034 as Development Candidate for Post-Bariatric Hypoglycemia

globenewswire.com
LLY

Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Novel Therapy Adoption Landscape | DelveInsight

prnewswire.com
ABBV JNJ LLY MRK PFE ABVX

Levin Papantonio - Federal Court Creates New MDL for Ozempic and Other GLP-1 Drugs Linked to Vision Loss (NAION)

globenewswire.com
LLY